• Title/Summary/Keyword: Heart Valve Prostheses

Search Result 40, Processing Time 0.025 seconds

In vitro study of downstream flow passing through heart valve prostheses (인공 심장판막 하류 유동의 in vitro 연구)

  • Kim Hyoung-Bum;Lanning Craig
    • Journal of the Korean Society of Visualization
    • /
    • v.4 no.1
    • /
    • pp.47-55
    • /
    • 2006
  • The left ventricular filling flow is now considered as an indicator which can be used for early diagnosing of cardiovascular diseases. Because the understanding of left ventricular flow physics is critical for this purpose, the downstream flow characteristics of the artificial heart valve are investigated using particle image velocimetry (PIV) method. In this study, we investigated the wake characteristics of flows passing through three different artificial valves (St.Jude medical bileaflet mechanical valve. Bjork-Shiley monostrut mechanical valve and St.Jude medical Biocor bio valve). The downstream flow field has remarkably altered according to the different valves. SJM MHV has the flow field similar to the pulsating circular jet and BS MHV has oblique pulsating jet. SJM BHV shows the similar flow field of clinical data of normal heart.

  • PDF

Clinical Experience of Carbomedics Valve (CarboMedies 기계판막의 임상적 연구)

  • 김병열
    • Journal of Chest Surgery
    • /
    • v.27 no.12
    • /
    • pp.995-1001
    • /
    • 1994
  • The CarboMedics valve prosthesis is a relatively new. low profile bileaflet prosthesis. During a 6 year period from Aug. 1988 to July 1994. 158 patients had CarboMedics prostheses implanted in the mitral [n=94], aortic [n=25], or aortic and mitral [n=39] in National Medical Center. Hospital mortality was 9.4% and the main cause of death was low output syndrome. Follow up was 96% complete, with 365.4 patient-years and a mean follow up of 30 months [ range 1 to 72 months ] . The overall actuarial 6 year survival rate was 91.61 3.47% and actuarial 6year freedom from all valve related complications was 73.9 7.67%. The linearized incidence of vavle related complications was as follows: thromboembolism 1.37%/patient-year ; valve thrombosis 0.82%/ patient-year ; anticoagulant related hemorrhage 0.85%/patient-year ; perivalvular leakage 0.55%/paitent-year: prosthetic valve endocarditis 0.82%/patient-year ; reoperation 1.37%/patient-year. There were no instances of structural failure. We conclude that the Carbomedics valve has a low rate of complications that further improves the quality of life in patients with heart valve prostheses.

  • PDF

Reoperation of Prosthetic Heart Valve; An Analysis of Operative Risks and Late Results (인공 심장판막의 재치환술 -수술 위험인자와 수술 결과의 분석-)

  • 김관민
    • Journal of Chest Surgery
    • /
    • v.28 no.1
    • /
    • pp.23-30
    • /
    • 1995
  • From January 1985 to December 1992, of 1257 patients who underwent a heart valve replacement 210 [16.8% underwent reoperation on prosthetic heart valves, and 6 of them had a second valve reoperation. The indications for reoperation were structural deterioration [176 cases, 81.5% , prosthetic valve endocarditis [25 cases, 11.6% , paravalvular leak [12 cases, 5.6% , valve thrombosis [2 cases, 0.9% and ascending aortic aneurysm [1 case, 0.4% . Prosthetic valve failure developed most frequently in mitral position [57.9% and prosthetic valve endocarditis and paravalvular leak developed significantly in the aortic valve [40%, 75% [P<0.02 . Mean intervals between the primary valve operation and reoperation were 105.3$\pm$28.4 months in the case of prosthetic valve failure, 61.5$\pm$38.5 months in prosthetic valve endocarditis, 26.8$\pm$31.2 months in paravalvualr leak, and 25.0$\pm$7.0 months in valve thrombosis. In bioprostheses, the intervals were in 102.0$\pm$23.9 months in the aortic valve, and 103.6$\pm$30.8 months in the mitral valve. The overall hospital mortality rate was 7.9% [17/26 : 15% in aortic valve reoperation [6/40 , 6.5% in reoperation on the mitral prostheses [9/135 and 5.7% in multiple valve replacement [2.35 . Low cardiac output syndrome was the most common cause of death [70.6% . Advanced New York Heart Association class [P=0.00298 , explant period [P=0.0031 , aortic cross-clamp time [P=0.0070 , prosthetic valve endocarditis [P=0.0101 , paravalvularr leak [P=0.0096 , and second reoperation [P=0.00036 were the independent risk factors, but age, sex, valve position and multiple valve replacement did not have any influence on operative mortality. Mean follow up period was 38.6$\pm$24.5 months and total patient follow up period was 633.3 patient year. Actuarial survival at 8 year was 97.3$\pm$3.0% and 5 year event-free survival was 80.0$\pm$13.7%. The surgical risk of reoperation on heart valve prostheses in the advanced NYHA class patients is higher, so reoperation before severe hemodynamic impairment occurs is recommended.

  • PDF

Dynamic Behavior Analysis of Mechanical Monoleaflet Heart Valve Prostheses (기계식 一葉심장밸브의 동적거동 해석)

  • 천길정
    • Transactions of the Korean Society of Mechanical Engineers
    • /
    • v.16 no.11
    • /
    • pp.2090-2097
    • /
    • 1992
  • In this paper, fluttering behavior of mechanical monloleaflet heart valve prosthesis was analyzed taking into consideration of the impact between the valve occluder and the stopper. The motion of valve occluder was modeled as a rotating system, and equations were derived by employing the moment equilibrium conditions. Lift force, drag force, gravity and buoyancy were considered as external forces acting on the valve occluder. The 4th order Runge-Kutta method was used to solve the equations. The results demonstrated that the occluder reaches steady eguilibrium position only after damped vibration. The mean damping ratio is in the range of 0.197-0.301. Fluttering frequency does not have any specific value, but varies as a function of time. It is in the range of 11-84Hz. Valve opening appears to be affected by the orientation of the valve relative to gravitational forces.

Impact Behavior Analysis of Mechanical Monoleaflet Heart Valve Prostheses in the Opening Phase

  • Cheon, Gill-Jeong;Chandran, K.B.
    • Journal of Biomedical Engineering Research
    • /
    • v.13 no.3
    • /
    • pp.235-244
    • /
    • 1992
  • In this paper, fluttering behavior of mechanical monoleaflet tilting disc heart valve prostheses during the opening phase was analyzed taking into consideration the impact between the occluder and the guiding strut at the fully open position. The motion of the valve occluder was modeled as a rotating system, and equations were derived by employing the moment equilibrium principle. Forces due to lift, drag, gravity and buoyancy were considered as external forces acting on the occluder. The 4th order Runge-Kutta method was used to solve the governing equations. The results iimonstrated that the occludes reaches steady equilibrium position only after damped vibration. Fluttering frequency varies as a function of time after opening and is in the range of 8-84 Hz. Valve opening appears to be affected by the orientation of the valve relative to gravitational force. The opening velocities are in the range of 0.65-1.42m/sec and the dynamic loads by impact of the occludes and the strut are in the range of 90-190 N.

  • PDF

Physical Analysis of the Prosthetic Valve Sound (기계판막치환후의 판막음에 대한 연구)

  • 조범구
    • Journal of Chest Surgery
    • /
    • v.22 no.4
    • /
    • pp.589-593
    • /
    • 1989
  • The frequency spectrum of the metallic closing sound and its loudness were measured by non invasive techniques in 66 patients. They had examined a total of 7 Carbomedics valve, 10 Duromedics valve, 11 St. Jude heart valve in mitral position and 8 Carbomedics, 10 Duromedics, 20 St. Jude heart valve prostheses functioning normally in aortic position. Statistical comparison of the loudness from sound produced by the three valves in each position, the following; The Carbomedics valve has the lowest average loudness, followed by the St. Jude medical valve, and finally the Edward Duromedics valve. And we analysis the changing factor of the loudness of valve sound, only the velocity of the flow through the valve influenced to the valve sound.

  • PDF

Clinical Study of Prosthetic Heart Valve Replacement with CarboMedics. (CarboMEdics 기계판막을 이용한 심장판막 치환술의 임상 연구)

  • 장원기;구자홍;조중구;김공수
    • Journal of Chest Surgery
    • /
    • v.33 no.1
    • /
    • pp.45-50
    • /
    • 2000
  • Background: The CarboMedics prosthetic heart valve was produced in an attempt to improve the existing valve designs and was especially concerned with easily the implantation and further reduction of turbulence. Precise positioning of the valve in situ was achieved by the abilityof the valve to rotate relative to the sewing ring. Improved monitoring is possible due to increased radiopacity and the dacron sewing ring is coated with carbon to reduce pannus overgrowth. The leaflets have an opening angle of 78 degrees that apparently allows a rapid synchronous closure The aim of this study was to analyze the clinical performance of the CarboMedics valve prostheses(45 mitral 13 aortic and 7 double aortic-mitral valve replacement) were implanted in 65 patients(mean age 48.75$\pm$9.74 years) Result: The operative mortality was 3.1%(2/65) causes of death were low cardiac output syndrome. Total follow up was 1831 patient-months and mean follow up was 29.06$\pm$10.97 months/patient. No structural failure hemorrhage valve thrombosis and late death have been observed. Embolism occurred at a rate of 0.65%/Patient-year. Actuarial survival and thrombo-mbolism free rate at 36 months were 96.9% and 98.4% respectively. Consclusions: The CarboMedics valve stands for low valve related complicatons.

  • PDF

Mechanical Valve Thrombosis -3 Cases- (기계 판막 혈전증 치험 3례 보고)

  • 김경훈;박성동
    • Journal of Chest Surgery
    • /
    • v.29 no.3
    • /
    • pp.326-330
    • /
    • 1996
  • Despite anticoagulation, systemic embolization and anticoagulant-related hemorrhage are the major drawbacks of heart valve replacement with mechanical prostheses. Among many predisposing factors, inadequacy of anticoagulation is the most important one. Surgery can be reserved for patients who do not response to thrombolytic therapy, We have experienced 3 cases of prosthetic valve thrombosis treated by thrombolytic therapy by use of urokinase and heparin. Two patients fully recovered and returned to their employments and active lives but 1 patient,died of intracerebral hemorrhage and infarction. We report prosthetic valve thrombosis thrombolytic therapy with urokinase and heparin which was detected and serially followed by 2-dimensional echocardiography, cinefluoro copy, and monitoring of Swan-Ganz catherterized pressures.

  • PDF

PIV System for the Flow Pattern Anaysis of Artificial Organs ; Applied to the In Vitro Test of Artificial Heart Valves

  • Lee, Dong-Hyeok;Seh, Soo-Won;An, Hyuk;Min, Byoung-Goo
    • Journal of Biomedical Engineering Research
    • /
    • v.15 no.4
    • /
    • pp.489-497
    • /
    • 1994
  • The most serious problems related to the cardiovascular prothesis are thrombosis and hemolysis. It is known that the flow pattern of cardiovascular prostheses is highly correlated with thrombosis and hemolysis. Laser Doppler Anemometry (LDA) is a usual method to get flow pattern, which is difficult to operate and has narrow measure region. Particle Image Velocimetry (PIV) can solve these problems. Because the flow speed of valve is too high to catch particles by CCD camera, high-speed camera (Hyspeed : Holland-Photonics) was used. The estimated maximum flow speed was 5m/sec and maximum trackable length is 0.5 cm, so the shutter speed was determined as 1000 frames per sec. Several image processing techniques (blurring, segmentation, morphology, etc) were used for the preprocessing. Particle tracking algorithm and 2-D interpolation technique which were necessary in making gridrized velocity pronto, were applied to this PIV program. By using Single-Pulse Multi-Frame particle tracking algorithm, some problems of PIV can be solved. To eliminate particles which penetrate the sheeted plane and to determine the direction of particle paths are these solving methods. 1-D relaxation fomula is modified to interpolate 2-D field. Parachute artificial heart valve which was developed by Seoul National University and Bjork-Shiely valve was testified. For each valve, different flow pattern, velocity profile, wall shear stress and mean velocity were obtained.

  • PDF

Reoperations on Heart Valve Prostheses (인공심장판막에 대한 재치환술)

  • 김재현;최세영;유영선;이광숙;윤경찬;박창권
    • Journal of Chest Surgery
    • /
    • v.31 no.12
    • /
    • pp.1165-1171
    • /
    • 1998
  • Background: All currently available mechanical and bioprosthetic valves are associated with various types of deterioration leading to dysfunction and/or valvular complications. Reoperation on prosthetic heart valves is increasingly under consideration for both clinical and prophylactic indications. This review was conducted to determine the factors affecting the risk of reoperation for prosthetic valve replacement. Material and method: From January 1985 to July 1996, 124 patients underwent reoperation on prosthetic heart valves, and 3 patients had a second valve reoperation. The causes of reoperation were prosthetic valve failure(96 cases, 77.4%), prosthetic valve thrombosis(16 cases, 12.9%), prosthetic valve endocarditis(7 cases, 5.6%) and paravalvular leak(5 cases, 4.1%). This article is based on the analysis of the experience with particular emphasis on the preoperative risks affecting the outcome of the reoperation. Result: Overall hospital mortality rate was 8.9%(11/124). Low cardiac output was the most common cause of death(70.6%). Left ventricular systolic dimension(p=0.001), New York Heart Association functional class IV(p=0.003) and serum creatinine level(p=0.007) were the independent risk factors, but age, sex and cardiothoracic ratio did not have any influence on the operative mortality. Follow-up period was ranged from 3 to 141 months (mean, 50.6 months). A late mortality rate was 1.8%. Conclusion: The surgical risk of reoperation on heart valve prostheses in the advanced NYHA class patients is higher, therefore reoperation is recommended before the hemodynamic impairment become severe.

  • PDF